insights_auto
Outlook: 0.0% bullish·86.7% bearish
Go to analysischevron_right
F1MC34:BVMF
Fmc Corp Bdr
R$13.41
arrow_downward
-1.40%(-0.19) 1D
Oct 20, 3:49:32 PM GMT-3 · BRL
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for F1MC34...
Open
R$13.74
High
R$13.74
Low
R$13.36
Mkt. cap
835.28M
Avg. vol.
16.05K
Volume
1.38K
52-wk high
R$81.08
52-wk low
R$12.31
Shares outstanding
155.55M
No. of employees
6K
Open
R$13.74
High
R$13.74
Low
R$13.36
Mkt. cap
835.28M
Avg. vol.
16.05K
Volume
1.38K
52-wk high
R$81.08
52-wk low
R$12.31
Shares outstanding
155.55M
No. of employees
6K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Barclays cuts FMC Corp. stock target to USD 4.00
Stock Traders Daily
·
16 hours ago
Liquidity Mapping Around (FMC) Price Events
Traders Union
·
1 day ago
What's behind FMC's latest 6.2% stock pullback?
Yahoo Finance
·
1 day ago
Don't Overlook FMC (FMC) International Revenue Trends While Assessing the Stock
Profile
FMC Corporation is an American chemical manufacturing company headquartered in Philadelphia, Pennsylvania, which originated as an insecticide producer in 1883 and later diversified into other industries. In 1941 at the beginning of U.S. direct involvement in WWII, the company received a contract to design and build amphibious tracked landing vehicles for the United States Department of War, and afterwards the company continued to diversify its products. FMC employs 7,000 people worldwide, and had gross revenues of US$4.7 billion in 2018. Wikipedia
About Fmc Corp Bdr
CEOPierre R Brondeau
Employees5.5K
Founded1883
HeadquartersPhiladelphia, Pennsylvania, United States
SectorFertilizer
Websitefmc.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 542.20M | 1.08B | 758.60M | 867.10M |
Cost of goods sold | 413.30M | 762.90M | 512.00M | 525.00M |
Cost of revenue | 413.30M | 762.90M | 512.00M | 525.00M |
Research and development expenses | 63.30M | 67.70M | 65.50M | 60.40M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 167.40M | 142.70M | 185.10M | 179.10M |
Operating expense | 230.70M | 217.50M | 250.60M | 239.50M |
Total operating expenses | 644.00M | 980.40M | 762.60M | 764.50M |
Operating income | -101.80M | 102.90M | -4.00M | 102.60M |
Other non operating income | - | - | - | - |
EBT including unusual items | -466.00M | -1.48B | -149.20M | -194.30M |
EBT excluding unusual items | -173.60M | 46.20M | -68.80M | 31.30M |
Income tax expense | 82.20M | 204.10M | 112.10M | -1.50M |
Effective tax rate | -17.64% | -13.75% | -75.13% | 0.77% |
Other operating expenses | - | 7.10M | - | - |
Net income | -569.30M | -1.72B | -281.30M | -186.60M |
Net profit margin | -105.00% | -158.85% | -37.08% | -21.52% |
Earnings per share | 0.89 | 1.20 | -0.23 | 0.26 |
Interest and investment income | - | - | - | - |
Interest expense | -64.10M | -64.40M | -64.80M | -71.30M |
Net interest expenses | -64.10M | -64.40M | -64.80M | -71.30M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -58.40M | 146.00M | 38.00M | 143.70M |
Gain or loss from assets sale | - | - | - | - |